GlassScriptPhysician profile
Paul Martin Friedman
NPI 1962495648
$130,721.76
in general payments reported to CMS, 2019-2025
34 companies · $15K in 2025
The $15K reported for 2025 was more than what 97% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $41K · 2021: $19K · 2022: $21K · 2023: $8,580 · 2024: $1,330 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,236 · Food and Beverage: $3,477 · Education: $42.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,467.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,235.80 |
| Food and Beverage | $3,477.34 |
| Education | $42.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $111,674.87 | 2019-2025 | Clear & Brilliant, Fraxel, Clear+Brilliant |
| Merz North America, INC. | $5,418.37 | 2019-2022 | |
| Abbvie INC. | $5,245.36 | 2019-2025 | |
| Galderma Laboratories, L.P. | $3,178.90 | 2019-2025 | Aklief, Oracea, Epsolay |
| Allergan, INC. | $1,680.83 | 2019-2023 | |
| Amgen INC. | $643.24 | 2020-2024 | Otezla |
| Genzyme Corporation | $466.56 | 2020-2025 | |
| Leo Pharma INC. | $364.22 | 2021-2023 | Adbry |
| Novartis Pharmaceuticals Corporation | $327.21 | 2023-2025 | |
| Revance Therapeutics, INC. | $228.06 | 2024-2025 | Daxxify |
| Janssen Biotech, INC. | $153.52 | 2022-2024 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $138.08 | 2020-2025 | Dupixent |
| Celgene Corporation | $134.36 | 2019 | |
| Vyne Pharmaceuticals INC. | $122.58 | 2020-2021 | |
| Epi Health, LLC | $110.98 | 2020-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $108.36 | 2023-2024 | Sotyktu |
| Pfizer INC. | $89.94 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $89.54 | 2019-2023 | |
| Strata Skin Sciences, INC. | $88.38 | 2022-2025 | Xtrac |
| Incyte Corporation | $74.25 | 2024 | Opzelura |
| Lilly USA, LLC | $69.48 | 2019-2023 | Taltz |
| Sun Pharmaceutical Industries INC. | $64.81 | 2019-2025 | Ilumya |
| Botanix Sb INC | $32.21 | 2025 | Sofdra |
| Integra Lifesciences Corporation | $29.26 | 2023 | Durasorb Monofilament Mesh |
| Musculoskeletal Transplant Foundation INC. | $28.94 | 2019 | |
| Arcutis Biotherapeutics, INC. | $23.55 | 2024 | Zoryve |
| Ucb, INC. | $21.28 | 2021 | |
| Almirall LLC | $20.45 | 2019 | |
| Dermavant Sciences, INC. | $17.96 | 2023 | Vtama |
| Biofrontera INC. | $17.67 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.14 | 2019 | |
| Journey Medical Corporation | $16.52 | 2019-2022 | |
| Aclaris Therapeutics, INC. | $15.00 | 2019 | |
| Apyx Medical Corporation | $9.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.